3 simple steps to lose weight as fast as possible. Read now

Semaglutide Dosage Chart: Full Titration Schedule

A complete semaglutide dosage chart for weight loss and diabetes, including the Wegovy titration steps, mg-to-units conversion, and missed-dose tips.

Evidence-based
This article is based on scientific evidence, written by experts, and fact-checked by experts.
We look at both sides of the argument and strive to be objective, unbiased, and honest.
Semaglutide Dosage Chart: Full Titration Guide
Last updated on June 15, 2026, and last reviewed by an expert on June 15, 2026.

If you’ve just been handed a prescription, the numbers can feel cryptic: 0.25, then 0.5, then up and up. This is the part nobody explains well at the pharmacy counter. Here you’ll get the full semaglutide dosage chart for both weight loss and diabetes, the reasoning behind each step, the mg-to-units math for compounded vials, and a plan for when you miss a shot.

Semaglutide Dosage Chart: Full Titration Guide

This is educational information, not medical advice. Semaglutide (Wegovy, Ozempic, Rybelsus) is a prescription-only medication and must be started, adjusted, and stopped under the supervision of a licensed prescriber. Some semaglutide is sold “for research use only” and is not FDA-approved for use in people. Don’t use this article to obtain or self-dose any unapproved product. Talk to your doctor or pharmacist before changing anything about your regimen, especially if you have a personal or family history of medullary thyroid cancer, MEN2, pancreatitis, or gallbladder disease.

The quick answer

For weight loss (Wegovy), the standard semaglutide dosing schedule climbs through five steps over about 16-20 weeks: 0.25 mg → 0.5 mg → 1.0 mg → 1.7 mg → 2.4 mg, holding each dose for four weeks before moving up. The 2.4 mg dose is the maintenance target. For type 2 diabetes (Ozempic), the schedule is shorter and tops out lower. The starting 0.25 mg dose isn’t really “treatment” — it’s a primer that lets your gut adjust before the doses that actually drive results.

The Wegovy semaglutide dosage chart for weight loss

This is the schedule the STEP 1 trial used, where adults averaged about 14.9% body-weight loss at 68 weeks on 2.4 mg.1 Each step lasts four weeks unless your prescriber says otherwise.

StepWeekly doseTypical weeksPurpose
10.25 mgWeeks 1-4Gut adjustment, minimal weight effect
20.5 mgWeeks 5-8First real appetite suppression
31.0 mgWeeks 9-12Building toward target
41.7 mgWeeks 13-16Near-maintenance
52.4 mgWeek 17 onwardMaintenance dose

A few things worth knowing:

To see roughly where you land in the schedule and what each step delivers, plug your details into the tracker below.

Microdosing GLP-1: What It Means and the Risks
Suggested read: Microdosing GLP-1: What It Means and the Risks

GLP-1 Dose Escalation Tracker

See the standard week-by-week titration for semaglutide and tirzepatide, and where you are on it.
Medication
This is the standard label titration, not personal medical advice. Your prescriber may move slower, pause, or hold a dose based on side effects and results. Never change your dose without them.

The Ozempic schedule for diabetes

Ozempic is the same molecule prescribed for type 2 diabetes, and its escalation is gentler and lower. Many people are managed at 0.5 mg or 1.0 mg; the 2.0 mg dose was added later for tighter glucose control.

StepWeekly doseTypical timing
10.25 mgWeeks 1-4 (starting dose)
20.5 mgWeeks 5-8
31.0 mgWeek 9 onward, if needed
42.0 mgOptional, for added glycemic control

The big practical point: Ozempic and Wegovy are not interchangeable by dose. The pens deliver different fixed amounts, so you can’t simply swap one for the other to hit a weight-loss target. That’s a conversation for your prescriber, not a swap you make at home.

Why the dose climbs so slowly

The slow taper isn’t bureaucratic caution. Nausea, and the other GI side effects that make people quit, are dose-dependent. Step up too fast and your stomach revolts.

Semaglutide is a GLP-1 receptor agonist. It slows how fast your stomach empties and dials down appetite signaling in the brain, which is great for eating less but also why food can sit heavy and queasy early on. In efficacy and tolerability reviews of GLP-1 drugs, nausea, vomiting, diarrhea, and constipation are the most common complaints, and they cluster around dose increases.2 Gradual titration gives your gut receptors time to adapt, so each jump lands softer.

If you want the bigger picture on how these drugs work and who they’re for, the overview of GLP-1 medications for weight loss is a good companion read, and the rundown of semaglutide side effects covers what to expect and when to call your doctor.

Suggested read: Liraglutide vs Semaglutide: Daily vs Weekly GLP-1

What to do if a step isn’t tolerated

Hitting a wall at a dose step is common and usually fixable. Options your prescriber may use:

Persistent severe abdominal pain, repeated vomiting, or signs of gallbladder trouble are not “tough it out” situations — those warrant a call to your prescriber.

Semaglutide dosage in units: the compounded-vial math

Brand pens are pre-set, so you never think in units. But compounded semaglutide usually comes as a multi-dose vial drawn up with an insulin syringe, and that’s where people get confused — and where dosing errors happen.

The key fact: insulin syringe “units” measure volume, not the drug. On a U-100 syringe, 100 units = 1 mL. How many milligrams sit in each unit depends entirely on the vial’s concentration, which the compounding pharmacy sets.

Here’s the conversion for a common concentration. Always confirm your own vial’s strength on the label.

Prescribed doseIf vial is 1 mg/mLIf vial is 2.5 mg/mL
0.25 mg25 units (0.25 mL)10 units (0.10 mL)
0.5 mg50 units (0.50 mL)20 units (0.20 mL)
1.0 mg100 units (1.00 mL)40 units (0.40 mL)

The math is simple: units to draw = (dose in mg ÷ concentration in mg/mL) × 100. Get the concentration wrong and you can be off by 2-3x without noticing, which is exactly why this belongs in a pharmacist’s hands. The realities and legal gray areas of compounded GLP-1 products are worth understanding before you go this route, and if you’re handling lyophilized powder, the step-by-step on how to reconstitute peptides explains why your final concentration is whatever you make it.

Suggested read: Tirzepatide Side Effects: GI, Risks & Hair Loss

Missed a dose? Here’s the rule

Semaglutide’s long half-life (about a week) gives you a generous window.

Picking a consistent weekly day — and setting a phone reminder — prevents most of this.

How dosing compares to tirzepatide

People often ask whether to climb further or switch. Tirzepatide (Zepbound, Mounjaro) is a different molecule with its own titration ladder and somewhat higher average weight loss in trials — roughly 15-21% across doses in SURMOUNT-1.3 It also escalates slowly for the same nausea reasons.

Semaglutide (Wegovy)Tirzepatide (Zepbound)
Start dose0.25 mg/week2.5 mg/week
Maintenance options1.7 or 2.4 mg5, 10, or 15 mg
Titration interval~4 weeks/step~4 weeks/step
Trial avg. weight loss~14.9%1up to ~20.9%3

If you’re weighing the two, the semaglutide vs tirzepatide comparison digs into the trade-offs, and the tirzepatide dosage guide lays out its full ladder. Beyond the scale, semaglutide also lowered major cardiovascular events by about 20% in people with obesity and existing heart disease in the SELECT trial — a benefit that’s part of why some prescribers favor it.4

Bottom line

The semaglutide dosage chart isn’t complicated once you see the logic: start low at 0.25 mg, climb one step every four weeks, and land at a maintenance dose (1.7 or 2.4 mg for weight loss) you can actually live with. Slow titration is the whole point — it’s what keeps nausea manageable. With compounded vials, the mg-to-units conversion is where care matters most, so confirm your concentration and let a pharmacist check your math. And whatever the chart says, your prescriber’s plan for your body wins.


  1. Wilding JPH, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med. 2021;384(11):989-1002. PubMed ↩︎ ↩︎

  2. Ghusn W, Hurtado MD. Glucagon-like Receptor-1 agonists for obesity: Weight loss outcomes, tolerability, side effects, and risks. Obes Pillars. 2024;12:100127. PubMed ↩︎

  3. Jastreboff AM, et al. Tirzepatide Once Weekly for the Treatment of Obesity. N Engl J Med. 2022;387(3):205-216. PubMed ↩︎ ↩︎

  4. Lincoff AM, et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. N Engl J Med. 2023;389(24):2221-2232. PubMed ↩︎

Share this article: Facebook Pinterest WhatsApp Twitter / X Email
Share

More articles you might like

People who are reading “Semaglutide Dosage Chart: Full Titration Guide” also love these articles:

Topics

Browse all articles